510(k) K213517
K213517 is an FDA 510(k) premarket notification submitted by Beckman Coulter, Inc. for the device "Access Thyroglobulin Antibody II". The FDA issued a decision of Substantially Equivalent on Sep 26, 2023. The device falls under product code JZO (System, Test, Thyroid Autoantibody), a Class II device regulated under 21 CFR 866.5870. Beckman Coulter, Inc. has 280 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Sep 26, 2023
- Date Received
- Nov 3, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- System, Test, Thyroid Autoantibody
- Device Class
- Class II
- Regulation Number
- 866.5870
- Review Panel
- IM
- Submission Type
- 510(k)
Need the full FDA record for Beckman Coulter, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.